December 15th, 2015

DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Bayer Aktiengesellschaft and Encourages Investors with Losses of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Bayer Aktiengesellschaft (“Bayer” or “the Company”) (OTC: BAYRY, BAYZF) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Bayer failed to disclose that the acquisition of Monsanto would cause the Company to suffer from exposure to massive judgements and reputational damage if lawsuits related to Monsanto’s Roundup product were successful. The Company’s positive statements about the prospects of the Monsanto acquisition and the benefits it would create were false. Based on these facts, the Company’s public statements throughout the class period were false and materially misleading. When the market learned the truth about Bayer, investors suffered damages.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Contacts:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
info@schallfirm.com
www.schallfirm.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.